Caspase-9 Recombinant Antibody, FITC Conjugated

Product Specifications

Background

Involved in the activation cascade of caspases responsible for apoptosis execution. Binding of caspase-9 to Apaf-1 leads to activation of the protease which then cleaves and activates caspase-3. Promotes DNA damage-induced apoptosis in a ABL1/c-Abl-dependent manner. Proteolytically cleaves poly (ADP-ribose) polymerase (PARP) . Isoform 2 lacks activity is an dominant-negative inhibitor of caspase-9.

Synonyms

Caspase-9, Apoptotic protease Mch-6, Apoptotic protease-activating factor 3, ICE-like apoptotic protease 6, CASP-9, APAF-3, ICE-LAP6, CASP9

Swiss Prot

P55211

Host

Rabbit

Cross Reactivity

Human, Mouse

Target

Caspase-9

Clonality

Recombinant

Isotype

IgG

Conjugation

FITC

Source

Human Caspase-9 aa 200-350

Applications

WB, IF

Purification

Purified by Protein A.

Excitation Emission

494nm/518nm

Concentration

Lot dependent

Dilution

WB (1:300-5000), IF ()

Buffer

Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Modification

Unmodified

Storage Conditions

Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

NBP2-72777PCP 0.1 mL

Mouse Monoclonal MRCK Antibody (OTI12C12) [PerCP]

View Details

TP721451 10 µg

SLC2A12 Human Recombinant Protein, Synthetic Nanodisc

View Details

MBS1386881-01 0.02 mg (E-Coli)

Recombinant Staphylococcus epidermidis Phosphoribosylglycinamide formyltransferase (purN)

View Details

MBS1386881-02 0.1 mg (E-Coli)

Recombinant Staphylococcus epidermidis Phosphoribosylglycinamide formyltransferase (purN)

View Details

MBS1386881-03 0.02 mg (Yeast)

Recombinant Staphylococcus epidermidis Phosphoribosylglycinamide formyltransferase (purN)

View Details

MBS1386881-04 0.1 mg (Yeast)

Recombinant Staphylococcus epidermidis Phosphoribosylglycinamide formyltransferase (purN)

View Details